
This study explores the risk of breakthrough infection among patients with type 2 diabetes (T2D) and the risk of severe clinical outcomes after SARS‐CoV‐2 infection according to vaccination status. Patients with T2D showed an increased risk of breakthrough infections compared to those without T2D. In contrast, patients with T2D remain vulnerable to SARS‐CoV‐2 infection even after full vaccination.
Like
Save
Share